FZMD · Fuse Medical, Inc.
Market Cap
$2.22M
Shares
73.90M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$18.64M
-8.7%
FY2022
Net Income
$3.1M
+295.1%
FY2022
Gross Margin
61.9%
+3.4pp
FY2022
Operating Margin
-4.37%
+6.4pp
FY2022
Diluted EPS
$0.04
+300%
FY2022
Operating Cash Flow
$34.8K
+102%
FY2022
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $18.4M | $18.64M | $20.41M | $21.4M | $22.9M | $26.34M | $26.41M | $25.67M | $1.68M | $941.09K | — | — | |
| — | — | — | — | — | — | — | -$129.39K | -$7112 | $1177 | — | — | |
| $6.33M | $7.1M | $8.48M | $8.69M | $11.76M | $13.35M | $14.58M | $11.26M | $664.27K | $485.38K | — | — | |
| $12.07M | $11.54M | $11.94M | $12.7M | $11.14M | $12.99M | $11.82M | $14.41M | $1.01M | $455.7K | — | — | |
| — | 61.9% | 58.47% | 59.37% | 48.63% | 49.31% | 44.78% | 56.14% | 60.38% | 48.42% | — | — | |
| $6.73M | $6.54M | $7.01M | $6.54M | $8.47M | $8.47M | $5.32M | $4.17M | — | — | — | — | |
| $130.86K | $130.86K | $57.1K | $68.54K | $81.42K | $33.93K | — | — | — | — | — | — | |
| $134.74K | $137.4K | $67.64K | $104.14K | $107.07K | $49.69K | $14.52K | — | — | — | — | — | |
| $12.19M | $12.36M | $14.13M | $13.73M | $15.49M | $14.95M | $10.97M | $11.25M | $1.81M | $1.79M | $109.28K | $101.61K | |
| -$121.58K | -$815.07K | -$2.2M | -$1.03M | -$4.35M | -$1.96M | $858.86K | $3.16M | -$794.44K | -$1.33M | -$109.28K | -$101.61K | |
| — | -4.37% | -10.75% | -4.8% | -19% | -7.43% | 3.25% | 12.32% | -47.38% | -141.82% | — | — | |
| $13.15K | -$677.67K | -$2.13M | -$923.77K | -$4.24M | -$1.91M | $873.38K | — | — | — | — | — | |
| $213.03K | $171.29K | $78.23K | $94.95K | $121.63K | $133.94K | $161.67K | $146.92K | $6712 | $71.61K | $571 | — | |
| — | — | — | — | — | — | — | — | — | — | $30 | $30 | |
| $3.9M | $3.94M | $625.34K | -$385.59K | $1.81M | $5.53M | -$118.36K | -$146.92K | -$7112 | -$70.44K | -$571 | $30 | |
| $3.77M | $3.12M | -$1.57M | -$1.41M | -$2.54M | $3.57M | $740.5K | — | — | — | — | — | |
| $26.47K | $23.66K | $17.72K | $18.99K | $781.09K | -$386.78K | $40.82K | $51.63K | $0 | — | — | — | |
| $3.98M | $3.1M | -$1.59M | -$1.43M | -$3.32M | $3.96M | $699.68K | $3.02M | -$801.55K | -$1.41M | -$109.86K | -$101.58K | |
| — | 16.62% | -7.78% | -6.69% | -14.48% | 15.02% | 2.65% | 11.75% | -47.81% | -149.3% | — | — | |
| USD/shares | $0.05 | $0.04 | -$0.02 | -$0.02 | -$0.05 | $0.06 | $0.04 | $0.42 | — | — | — | — |
| USD/shares | — | $0.04 | -$0.02 | -$0.02 | -$0.05 | $0.05 | $0.04 | $0.33 | — | — | — | — |
| shares | — | 70.32M | 70.32M | 70.22M | 70.22M | 67.67M | 16.03M | 7.19M | 6.19M | 3.79M | — | — |
| shares | — | 77.86M | 70.32M | 70.22M | 70.22M | 73.93M | 19.47M | 9.21M | 6.19M | 3.79M | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Coverage backlog: 23 eligible filings and 0 covenant artifacts have no current-version terminal extraction result. This includes untouched sources and sources on the retry ladder.
No terminal debt extraction result is available yet; this is not evidence that the company has no debt.